16:28 EST Vaxcyte offering $500M in common stock at $64 per share, Bloomberg says
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PCVX:
- Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older
- Vaxcyte completes enrollment of Phase 1/2 study of VAX-31
- Vaxcyte appoints Whitney Jones as Chief People Officer
- Vaxcyte Appoints Whitney Jones as Chief People Officer